Proteolytic Cleavage of Opa1 Stimulates Mitochondrial Inner Membrane Fusion and Couples Fusion to Oxidative Phosphorylation  by Mishra, Prashant et al.
Cell Metabolism
ArticleProteolytic Cleavage of Opa1 Stimulates
Mitochondrial Inner Membrane Fusion
and Couples Fusion to Oxidative Phosphorylation
Prashant Mishra,1 Valerio Carelli,3 Giovanni Manfredi,4 and David C. Chan1,2,*
1Division of Biology and Biological Engineering
2Howard Hughes Medical Institute
California Institute of Technology, Pasadena, CA 91125, USA
3IRCCS Istituto delle Scienze Neurologiche di Bologna and Department of Biomedical and NeuroMotor Sciences, University of Bologna,
Via Altura 3, 40139 Bologna, Italy
4Departments of Neurology and Neuroscience, Weill Medical College of Cornell University, 1300 York Avenue, A501, New York,
NY 10065, USA
*Correspondence: dchan@caltech.edu
http://dx.doi.org/10.1016/j.cmet.2014.03.011SUMMARY
Mitochondrial fusion is essential for maintenance of
mitochondrial function. The mitofusin GTPases con-
trol mitochondrial outer membrane fusion, whereas
the dynamin-related GTPase Opa1 mediates inner
membrane fusion. We show that mitochondrial inner
membrane fusion is tuned by the level of oxidative
phosphorylation (OXPHOS), whereas outer mem-
brane fusion is insensitive. Consequently, cells from
patients with pathogenic mtDNA mutations show a
selective defect in mitochondrial inner membrane
fusion. In elucidating the molecular mechanism of
OXPHOS-stimulated fusion, we uncover that real-
time proteolytic processing of Opa1 stimulates
mitochondrial inner membrane fusion. OXPHOS-
stimulated mitochondrial fusion operates through
Yme1L, which cleaves Opa1 more efficiently under
high OXPHOS conditions. Engineered cleavage of
Opa1 is sufficient to mediate inner membrane fusion,
regardless of respiratory state. Proteolytic cleavage
therefore stimulates the membrane fusion activity
of Opa1, and this feature is exploited to dynamically
couple mitochondrial fusion to cellular metabolism.
INTRODUCTION
Within a cell, the mitochondria exist as a population of dynamic
organelles that continually interact through fusion and fission
(Chan, 2012; Westermann, 2010; Youle and van der Bliek,
2012). These opposing processes underlie mitochondrial
dynamics and serve to maintain the quality of the mitochondrial
population. Mitochondrial dynamics has important roles in
mitochondrial DNA (mtDNA) stability, respiratory capacity,
apoptosis, response to cellular stress, and mitophagy. Mito-
chondrial fusion is therefore likely to be regulated by cellular
physiology, but this issue is poorly understood.630 Cell Metabolism 19, 630–641, April 1, 2014 ª2014 Elsevier Inc.Mitochondrial fusion requires coordination of outer membrane
(OM) and innermembrane (IM) fusion. OMand IM fusion normally
occur in unison in vivo, but can be experimentally uncoupled
(Malka et al., 2005; Meeusen et al., 2004, 2006). OM fusion
requires the mitofusins Mfn1 and Mfn2, membrane-bound
GTPases located on the OM. IM fusion requires the dynamin-
related GTPase Opa1 (Meeusen et al., 2006; Song et al., 2009).
Each Opa1 splice form (Delettre et al., 2001) encodes an Opa1
precursor that is imported into the mitochondrion, where the
N-terminal mitochondrial targeting sequence is removed to
produce a long isoform of Opa1 (l-Opa1) embedded in the IM.
At steady state, about half of Opa1 exists as l-Opa1, with the
remainder cleaved at S1 or S2 sites to create short forms
(s-Opa1) that are no longer membrane anchored (Ishihara
et al., 2006). The Oma1 protease is required for S1 cleavage,
which occurs at basal levels but can be dramatically induced
by depolarization of mitochondria (Ehses et al., 2009; Head
et al., 2009). The Yme1L protease is involved in cleavage at S2
(Griparic et al., 2007; Song et al., 2007). A combination of long
and short Opa1 isoforms is necessary for fusion (DeVay et al.,
2009; Herlan et al., 2003; Song et al., 2007).
Cellular bioenergetics affectsmitochondrial dynamics, but this
relationship is understood only in vague terms and is compli-
cated by conflicting data. Mitochondrial fusion in vitro requires
ATP or an energy regenerating system (Hoppins et al., 2011;
Meeusen et al., 2004; Schauss et al., 2010), but the basis of
this requirement is unclear. Some mammalian cells have been
reported to respond to galactose medium by enhancing mito-
chondria tubulation over a period of 2 weeks (Rossignol et al.,
2004), but it is unknown whether this morphology change re-
flects an increase in fusion or a decrease in fission. Moreover,
other cell types appear to have no response (Rossignol et al.,
2004). Some mammalian cells with OXPHOS defects contain
fragmented mitochondria (Koopman et al., 2005; Kwong et al.,
2007; Sauvanet et al., 2010), and yeast cells with defective
mtDNA show reduced mitochondrial fusion (Sauvanet et al.,
2012). It is unknown whether these changes are direct or indirect
consequences of mitochondrial dysfunction. However, there are
also well-documented cases of patient cells with OXPHOS
defects that have no apparent change in mitochondrial
Figure 1. Oxidative Conditions Stimulate
Mitochondrial Fusion
(A) Inducing oxygen consumption with oxidative
media. MEFs were grown in glucose-containing
media and then switched to glucose-, galactose-,
or acetoacetate-containing media. Error bars
indicate standard deviations.
(B) Quantitation of mitochondrial morphology at
24 hr after media shift. Cells were classified as
having mostly fragmented mitochondria, short
tubular mitochondria or long tubular mitochondria.
Error bars indicate standard deviations.
(C) Representative images of mitochondrial
morphology (matrix-targeted DsRed) at 24 hr after
media shift. Scale bar, 5 mm.
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Opa1 Cleavage Stimulates Mitochondrial Fusionmorphology (Guillery et al., 2008a; Handran et al., 1997; Huck-
riede et al., 1995; Sauvanet et al., 2010). In addition, some mito-
chondrial fusion does proceed in mammalian or yeast cells
entirely lacking mtDNA (r0 cells), indicating that mitochondrial
fusion can occur in the absence of OXPHOS (Hermann et al.,
1998; Legros et al., 2002). These disparate observations do
not suggest a simple relationship between OXPHOS activity
and mitochondrial fusion.
To resolve these issues, we studied the dependence of mito-
chondrial fusion on the respiratory activity of mitochondria
in vitro and in vivo. Using an in vitro fusion assay with isolated
mitochondria, we find that OXPHOS stimulates the coupling be-
tween OM and IM fusion. This regulatory mechanism extends to
live cells, and patient cells with mtDNA mutations show a selec-
tive defect in IM fusion. In the course of identifying the molecular
basis for this regulation, we discovered that ongoing cleavage of
l-Opa1 stimulates IM fusion. OXPHOS upregulates IM fusion by
enhancing Opa1 cleavage by Yme1L. Indeed, by artificially acti-
vating Opa1 cleavage, we can trigger IM fusion in vitro. These
results indicate that dynamin-related proteins can be activated
for membrane fusion by proteolysis and provide a molecular
link between cellular metabolism and mitochondrial fusion.
RESULTS
Oxidative Culture Conditions Promote Mitochondrial
Elongation
Given the central role of mitochondria in energy production, we
speculated that mitochondrial dynamics might be responsiveCell Metabolism 19, 630to cellular metabolism. We used 96-well
oxygen consumption measurements to
identify specialized media formulations
that robustly affect the respiratory activity
of mitochondria in culturedmouse embry-
onic fibroblasts (MEFs). Starting with
pyruvate-lacking media with a moderate
concentration (10 mM) of glucose, we
found that a switch to media containing
galactose or ketone bodies (acetoace-
tate) as the carbon source results in a
1.5- to 2-fold increase in mitochondrial
respiration within 30 min (Figure 1A). Atthis early time, there are no changes in mitochondrial
morphology, but by 24 hr a dramatic restructuring is apparent.
Whereas cells maintained in customized glycolytic (glucose-
containing) media show mostly fragmented and short tubular
mitochondria, cells shifted to oxidative media (galactose or ace-
toacetate) display an increase in long tubular mitochondria
(Figures 1B and 1C). Conversely, shifting cells from glucose-
free media to glycolytic media results in a rapid reduction in res-
piratory activity that is accompanied by a dramatic shortening of
mitochondrial length over 24 hr (Figures S1A–S1C). Mfn1 null
cells show an increase in respiration in oxidative media but do
not elongate their mitochondria (Figures S1D–S1F), indicating
that the rise in respiration is a primary response that is not due
to a morphology change. The elongation is not associated with
changes in the levels of fusion and fission machinery compo-
nents (Figure S1G), nor mitochondrial accumulation or phos-
phorylation of Drp1 (a key component of the fission machinery),
mechanisms previously shown (Cereghetti et al., 2008; Cribbs
and Strack, 2007) to regulate fission (Figures S1H and S1I).
IM Fusion In Vitro Is Tuned by OXPHOS Activity
To directly probe the relationship between OXPHOS and mito-
chondrial fusion, we turned to an in vitro fusion assay involving
isolated organelles (Figure 2A). Mitochondrial fusion is a multi-
step process consisting of OM fusion followed by IM fusion
(Meeusen et al., 2004). We developed an in vitro fusion assay
with a fluorescent readout that allows these steps to be resolved.
Mitochondria were separately isolated from two cell lines stably
expressing fluorescent submitochondrial markers. One cell line–641, April 1, 2014 ª2014 Elsevier Inc. 631
Figure 2. OXPHOS Stimulates Inner Membrane Fusion In Vitro
(A) Schematic of the in vitro fusion assay. Mitochondria containing OM-targeted GFP and matrix CFP were mixed with mitochondria containing matrix RFP. Full
fusion events (both OM and IM fusion) are indicated by colocalized CFP and RFP matrices that are surrounded by a single GFP membrane. OM fusion
intermediates are indicated by apposed but distinct CFP and RFP matrices that are surrounded by a single GFP membrane.
(B) Image of an in vitro fusion reaction showing unfused mitochondria, OM fusion intermediates (arrow), and full fusion events (arrowhead). Scale bar, 1 mm.
(C) Dependence of OM and IM in vitro fusion events on respiratory substrates. Events are plotted as percentage of total mitochondria.
(D)Sensitivityof in vitro fusion toETC inhibition in respiratory conditions.ADPandGTParepresent inall reactions.Pyruvate,malate (‘‘Pyr/Mal,’’ complex I substrates),
or succinate (complex II substrate) was added as indicated. The following drugs were tested: rotenone (complex I inhibitor), atpenin A5 (AA5, complex II inhibitor),
antimycin A (Ant A, complex III inhibitor), potassium cyanide (KCN, complex IV inhibitor), and oligomycin (oligo, complex V inhibitor). Same color schemes as (C).
(E) Partial support of in vitro fusion events by ATP or the tricarboxylic acid cycle. Same color scheme as (C). GTP and ATP were added as indicated. TCA:
substrates for the tricarboxylic acid cycle (a-ketoglutarate, aspartate, NADH).
(F) OM (top) and IM (bottom) fusion rates in vitro as a function of oxygen consumption rate. All error bars indicate standard deviations.
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to the matrix; the other expressed RFP targeted to the matrix.
This combination of markers allows facile scoring of both OM
and IM fusion events simultaneously in a single reaction after
mixing (Figures 2B and S2A). Full fusion events are defined by
coupled OM and IM fusion and result in complete colocalization
of CFP and RFP fluorescence, which are surrounded by a single
GFP-labeled membrane (Figure S2B). OM events that do not
progress to IM fusion result in neighboring CFP and RFP com-
partments that are surrounded by a single GFP-labeled OM (Fig-
ure S2C). With optimal reaction conditions (see later), greater
than 20% of the mitochondria show full fusion, with very few
intermediates trapped at the initial stage of OM fusion (Fig-
ure 2C). This fusion assay shows several expected features:
OM fusion depends on both GTP hydrolysis and mitofusins,
whereas IM fusion requires Opa1 (Figures S2D and S2E).
We found that efficient coupling of OM and IM fusion requires
the presence of respiratory substrates such as succinate and
ADP for respiration via complex II of the electron transport chain
(ETC) (Figure 2C). When both substrate and ADP are supplied, >
95% of OM fusion events culminate in IM fusion. These condi-632 Cell Metabolism 19, 630–641, April 1, 2014 ª2014 Elsevier Inc.tions correspond to state 3 respiration (Chance and Williams,
1955), where substrate and ADP are not limiting, and the ETC
is highly active. In contrast, when both succinate and ADP are
absent, OM fusion proceeds at normal levels but is completely
uncoupled from IM fusion (Figure 2C). When only ADP or succi-
nate is omitted, about half of the OM fusion events progress to
full fusion. This effect is probably due to low levels of endo-
genous ADP and substrate present in themitochondrial prepara-
tions. Consistent with this idea, preincubation of mitochondria
with ADP to deplete endogenous substrate abolishes this effect
(Figure S2F).
These reconstitution data suggest that OXPHOS rates can
control mitochondrial fusion efficiency at the level of IM fusion.
Oxygen consumption measurements indicated that our isolated
mitochondria are highly active, intact, and responsive to phar-
macologic inhibition of the ETC (Figures S2G and S2H). We
therefore tested the effect of OXPHOS inhibition on OM and IM
fusion. With the complex II substrate succinate, inhibition of
ETC complex II, III, IV, or the ATP synthase (complex V) potently
blocks IM fusion but leaves OM fusion intact (Figure 2D). The
inhibitory effect of the complex II inhibitor atpenin A5 can be
Figure 3. Inner Membrane Fusion Is In-
hibited under Glycolytic Conditions In Vivo
(A) OM fusion in wild-type MEFs. At time t = 0 min,
PA-GFP in the OM was activated in a region of in-
terest (red box). Dilution of the PA-GFP signal was
followed every 3 min for 30 min. Representative im-
agesat 0minand30minare shown.Scalebar, 5mm.
(B) IM fusion in wild-type MEFs. Same as in (A), but
using PA-GFP targeted to the matrix. Scale bar,
5 mm.
(C) OM and IM fusion rates in vivo in glycolytic and
oxidative media, measured by dilution of PA-GFP.
The p values were calculated for the slopes (pixel
intensity versus time) using the Student’s t test.
(D) OM and IM fusion rates in vivo in the presence
and absenceof the complex III inhibitor antimycin A
(Ant A). As a negative control, data from mitofusin-
deficient MEFs (Mfn: Mfn1/, Mfn2/) are
shown. The p values were calculated as in (C). All
error bars indicate standard deviations. *p < 0.01.
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malate. Analogously, the complex I inhibitor rotenone potently
blocks IM fusion driven by complex I substrates (pyruvate/
malate) but does not inhibit fusion driven by succinate. In
contrast, OM fusion occurs at normal levels in mitochondria
with impaired OXPHOS.
We tested whether inactivation of Opa1 via enhanced
processing might be responsible for the sensitivity of IM
fusion to respiration inhibition. Loss of membrane potential
through the addition of uncouplers (e.g., CCCP) causes in-
activation of Opa1 via complete cleavage of the long form (Du-
vezin-Caubet et al., 2006; Ishihara et al., 2006) by the protease
Oma1 (Ehses et al., 2009; Head et al., 2009). In our in vitro
fusion reactions, CCCP induced efficient cleavage of Opa1 to
short isoforms as expected (Figure S2I). In contrast, pharma-
cologic inhibition of OXPHOS or the lack of respiratory sub-
strates did not cause such aberrant Opa1 processing (Figures
S2I and S2J). Thus, the sensitivity of IM fusion to respiration
is not a consequence of proteolytic inactivation of Opa1. In
addition, mitochondrial membrane potential does not appear
to be the key factor, because oligomycin treatment results in
loss of IM fusion despite hyperpolarization of the mitochondria
(Figure S2K).Cell Metabolism 19, 630The ultimate function of the ETC is to
drive formation of ATP in the mitochon-
drial matrix via complex V activity. When
ATP is added to the fusion reaction in
the absence of respiratory substrates,
we obtained a partial rescue of IM fusion
(Figure 2E). This effect was not due to a
stimulation of OXPHOS, via contami-
nating ATPases that may generate ADP
(Figure S2L). Similarly, production of
ATP via induction of substrate level phos-
phorylation in the tricarboxcylic acid
(TCA) cycle partially rescues IM fusion in
the absence of respiratory substrates
(Figure 2E).Taken together, these data reveal two important features of
mitochondrial fusion in vitro. First, OM fusion is highly active as
long as mitofusins and GTP are present. Second, ETC activity
can stimulate mitochondrial IM fusion in vitro. To extend this
latter concept, we tested whether the activity of the ETC might
directly tune the levels of mitochondrial fusion. By systematically
varying the availability of respiratory substrates in vitro, we found
that the IM fusion rate closely correlates with oxygen consump-
tion, whereas OM fusion is insensitive (Figures 2F and S2M).
IM Fusion in Cultured Cells Can Be Controlled by
OXPHOS Activity
To test whether these in vitro insights apply to intact cells, we
measured mitochondrial fusion in cells as a function of respira-
tion. Utilizing a photoactivatable GFP (PA-GFP) targeted to either
the OM or matrix, we measured OM and IM fusion rates, respec-
tively, by following the decline in PA-GFP intensity due to fusion
(Figure 3). Consistent with our in vitro results, OM fusion rates are
statistically indistinguishable in glycolytic versus oxidative
media, whereas IM fusion rates increase in oxidative media (Fig-
ures 3A–3C). This increase in IM fusion is apparent at 1–2 hr after
the media shift, well before any obvious change in the steady-
state morphology of mitochondria. Similarly, inhibition of–641, April 1, 2014 ª2014 Elsevier Inc. 633
Figure 4. Pathogenic mtDNA Mutations Impair OXPHOS-Driven IM Fusion
(A) Failure of ND1 (complex I mutant) and COXI (complex IV mutant) cells to elongate mitochondria when shifted to oxidative media for 4 hr. Mitochondria were
visualized via expression of matrix-targeted DsRed. Scale bar, 5 mm.
(B) Quantification of mitochondrial morphology in wild-type and mutant cells in glycolytic (‘‘Glucose’’) versus oxidative (‘‘Acetoacetate’’) media.
(C) Defective IM fusion in vitro in mitochondria of mutant cells. All reactions contain GTP. Pyr, pyruvate; Mal, malate; Suc, succinate; TCA, substrates for the
tricarboxylic acid cycle (a-ketoglutarate, aspartate, NADH). All error bars indicate standard deviations.
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inent decrease in IM fusion efficiency with no observable effect
on OM fusion (Figure 3D).
By tracking individually labeled mitochondria, we could
directly visualize the coupling of OM and IM fusion (Figure S3).
In customized glycolytic media, 38% of OM fusion events did
not immediately proceed to IM fusion (28 of 74). In contrast, in
oxidative media, only 7% of OM fusion events (5 of 70) did not
proceed to IM fusion. Thus, OXPHOS activity has a selective
effect on the IM fusion efficiency. Under glycolytic conditions,
many OM fusion events are uncoupled from IM fusion. These
events were subsequently resolved by either fission or a
1–2 min delay in IM fusion (Figures S3B and S3C). Therefore,
uncoupling of OM fusion from IM fusion can occur under physi-
ological conditions. Because nonproductive OM fusion interme-
diates are resolved by fission, the uncoupling rate can regulate
the overall fusion rate of the matrix compartment.
Mitochondrial Encephalomyopathies Cause a Selective
Defect in IM Fusion
Genetic defects in the OXPHOS machinery cause mitochondrial
encephalomyopathies (DiMauro and Schon, 2003) that are asso-634 Cell Metabolism 19, 630–641, April 1, 2014 ª2014 Elsevier Inc.ciated with defective mitochondrial ATP production, as well as
muscular and nervous system pathology. Our findings above
suggest that mitochondrial IM fusion rates may be depressed
in these patients, especially under oxidative conditions. To test
this hypothesis, we used isogenic cybrid cell lines harboring
homoplasmic mtDNAmutations derived from patients with mito-
chondrial encephalomyopathy. The ‘‘ND1’’ cell line has severely
reduced complex I activity, with no effect on complex II-driven
respiration (Baracca et al., 2005). The ‘‘COXI’’ cell line is defec-
tive in complex IV and therefore has no measurable respiration
via either complex I or complex II (Kwong et al., 2007). When
grown in glucose-containing media, these two mutant cell lines
have mitochondrial morphologies that are indistinguishable
from that of wild-type cells (Figures 4A and 4B). Upon transfer
to oxidative media, however, mutant cells are severely defective
in mitochondrial elongation.
To quantify intrinsic mitochondrial fusion rates, we returned to
the in vitro fusion assay. Mitochondria from ND1 and COXI
mutant cells exhibit a specific defect in IM fusion, with no reduc-
tion of OM fusion rates (Figure 4C). Importantly, the IM fusion
defect of ND1 mitochondria, but not COXI mitochondria, can
be fully rescued by driving OXPHOS with complex II substrates.
Figure 5. Opa1 Processing at Site S2 Is
Necessary for OXPHOS-Induced Fusion
(A) Inhibition of IM fusion events in vitro by
o-phenanthroline. All reactions contain GTP. Suc,
succinate; o-phe, o-phenanthroline. Error bars
indicate standard deviations.
(B) Schematic of Opa1mRNA splice forms 1 and 7,
showing locations of the S1 and S2 cleavage sites.
(C) Processing at the S1 (top two panels) and S2
(bottom two panels) sites of myc-Opa1 in vitro in
response to respiratory conditions or ATP. Oxa1
levels are shown as a control. Processing to the
short form of myc-Opa1 isoform 7DS1 (arrow)
occurs in response to respiratory conditions.
(D) Processing at the Opa1 S2 site in vitro in
response to ETC inhibition. Substrate (succinate,
ADP) and drugs (antimycin A [ant A], oligomycin
[oligo], and o-phenanthroline [o-phe]) were added
as indicated.
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by substrate level phosphorylation. Therefore, these disease
cells have no intrinsic defect in the mitochondrial fusion machin-
ery but have a specific defect in OXPHOS-driven mitochondrial
fusion.
Proteolytic Cleavage of Opa1 Is Required for OXPHOS-
Stimulated Fusion
To understand the molecular basis of OXPHOS-induced
membrane fusion, we screened for pharmacologic agents that
specifically inhibit this process. Numerous compounds—
including kinase and phosphatase inhibitors, deacetylase inhib-
itors, and oxidizing and reducing agents—had no effect on inner
or OM fusion (Figure S4A). The metalloprotease inhibitor o-phe-
nanthroline, however, completely blocked IM fusion while leav-
ing OM fusion intact (Figure 5A). This inhibitory effect was not
due to an inhibition of respiration (Figure S4B) and could not
be rescued by addition of ATP, suggesting the ATPmaywork up-
stream of the step inhibited by o-phenanthroline.
Intriguingly, Opa1, the central protein involved in IM fusion, is
proteolytically processed by two metalloproteases, Oma1 and
Yme1L. Oma1 processes l-Opa1 at the S1 cleavage site,
whereas Yme1L processes l-Opa1 isoforms containing the S2
cleavage site (Figure 5B). Oma1 activity is inhibited by o-phenan-
throline (Ehses et al., 2009; Kaser et al., 2003), and Yme1L be-
longs to a family of zinc-binding proteases (Langklotz et al.,
2012) that should also be inhibited by metal chelation. These
observations suggest the possibility that ongoing Opa1 cleavage
is required for IM fusion. If this idea is correct, cleavage events
should accumulate during the course of a productive fusion re-Cell Metabolism 19, 630action. We measured cleavage at S1 in
mitochondria containing Myc-tagged
Opa1 isoform 1 (which only contains
the S1 site) and cleavage at S2 in mito-
chondria containing Opa1 isoform 7DS1
(which only contains the S2 site).
Processing at S2 was stimulated by
respiratory substrates or ATP (Figure 5C),
conditions that promote IM fusion.This stimulation was eliminated by the OXPHOS inhibitors
antimycin A and oligomycin and by o-phenanthroline (Figure 5D).
Thus, cleavage at S2 correlates with mitochondrial IM fusion
in vitro. S1 cleavagewas not stimulated by conditions permissive
for IM fusion (Figure 5C). We observed similar stimulation of
S2 (but not S1) cleavage in cells cultured under oxidative con-
ditions (Figures S4C and S4D). Consistent with a role for
S2 cleavage, cells containing mtDNA mutations in ND1 or
COX1 show a selective reduction in S2 cleavage products
(Figure S4E).
To further define the genetic requirements for OXPHOS-
stimulated fusion, we examined cells lacking Oma1 or Yme1L.
Like wild-type cells, Oma1 null MEFs respond to respiratory
conditions by mitochondrial elongation (Figures S5A and S5B).
In contrast, knockdown of Yme1L (Figures 6A, 6B, and S5C)
prevents mitochondrial elongation induced by oxidative media,
despite a normal mitochondrial respiration response (Fig-
ure S5D). This defect was rescued by expression of an
RNAi-resistant form of Yme1L (Figure S5E). The inhibition of
mitochondrial elongation is due to a failure to stimulate IM fusion
under oxidative conditions, with no effect on OM fusion
(Figures 6C, 6D, S5F, and S5G). IM fusion rates in glycolytic
conditions were unaffected (Figure 6C). To further test the
role of Yme1L, we designed siRNAs to selectively remove
Opa1 mRNA splice forms that contain exon 5b, which encodes
the S2 cleavage site. Two independent siRNAs against exon
5b blocked OXPHOS-stimulated mitochondrial elongation
(Figures 6E, 6F, S5H, and S5I). In contrast, neither Yme1L nor
Oma1 was singly required for mitochondrial elongation stimu-
lated by starvation or cycloheximide treatment (Figure S5J).–641, April 1, 2014 ª2014 Elsevier Inc. 635
Figure 6. Yme1L Is Necessary for OXPHOS-Induced Fusion
(A) Representative images of mitochondrial morphology in Yme1L-depleted
MEFs at 24 hr after shifting to glycolytic (top) or oxidative (bottom) media.
Mitochondria were visualized via staining for Tom20, a mitochondrial outer
membrane protein. Scale bar, 5 mm.
(B) Quantification of mitochondrial morphology in control and Yme1L-depleted
cells in glycolytic (‘‘Glucose’’) versus oxidative (‘‘Acetoacetate’’) media.
(C) OM fusion rates (top) and IM fusion rates (bottom) measured by PA-GFP
dilution in vivo under glycolytic conditions. Yme1L-knockdown cells are
compared with control cells.
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636 Cell Metabolism 19, 630–641, April 1, 2014 ª2014 Elsevier Inc.Proteolytic Activation of Opa1 Is Sufficient to Trigger IM
Fusion
Mitochondrial dysfunction is often associated with increased
Opa1 cleavage (Duvezin-Caubet et al., 2006; Guillery et al.,
2008b; Ishihara et al., 2006), leading to the idea that Opa1 cleav-
age inactivates mitochondrial fusion. Our data suggest the
opposite hypothesis, that real-time proteolysis of Opa1 stimu-
lates fusion. To expand this idea, we asked whether artificial
cleavage of Opa1 is sufficient to trigger IM fusion. We used an
engineered version of Opa1 with no endogenous cleavage sites
(isoform 1DS1) (Song et al., 2007) and introduced an artificial
cleavage site recognized by the tobacco etch virus (TEV) prote-
ase at the position of the S2 site. This Opa1 variant was ex-
pressed in Opa1 null MEFs, and isolated mitochondria were
analyzed in an in vitro fusion reaction. Mixed mitochondria
were allowed to enter the initial stage of fusion, during which
OM fusion occurred. We treated the mitochondria with a low
concentration of digitonin that permeabilized the OM but left
the IM intact (Figure S6A), and then added TEV protease to the
reaction (Figure 7A). Strikingly, addition of digitonin and TEV
were sufficient to promote IM fusion events, despite the absence
of respiratory substrates and ATP (Figure 7B). Importantly, these
events also bypassed the inhibitory effect of o-phenanthroline.
Controls indicated that both digitonin and TEV were necessary
to activate fusion, and no activation was observed with mito-
chondria containing an Opa1 variant lacking the TEV site (Fig-
ure 7B). Thus, proteolytic cleavage of Opa1 at S2 stimulates
IM fusion.
These results prompted us to examine whether cleavage at S1
could similarly stimulate IM fusion. Opa1 splice forms that
contain only an S1 site are sufficient to restore mitochondrial
fusion to Opa1 null cells (Song et al., 2007). Mitochondria
containing an Opa1 variant with a TEV site in place of S1 showed
IM fusion triggered by digitonin and TEV (Figure 7C). Thus, acti-
vation of Opa1 is not limited to the S2 site; cleavage appears to
be a general mechanism to stimulate IM fusion.
Treatment of cells or mitochondria with CCCP is known to
inactivate mitochondrial fusion by inducing complete l-Opa1
cleavage at S1 by Oma1 (Ehses et al., 2009; Head et al., 2009;
Ishihara et al., 2006). As a result, cleavage at S1 induced by
CCCP treatment is generally thought to inactivate Opa1 function.
In contrast, we wondered whether CCCP treatment might be
able to paradoxically stimulate IM fusion of mitochondria stalled
after OM fusion by respiratory inhibition. Wild-type mitochondria
were allowed to undergo OM fusion in vitro, and then CCCP was
added (Figure 7D). Remarkably, CCCP treatment stimulated IM
fusion, removing the normal requirement for respiratory sub-
strates (Figure 7E). Unlike OXPHOS-stimulated fusion, the
CCCP-induced fusion is resistant to oligomycin treatment. It is,(D) Same as (C), but under oxidative conditions. The p values were calculated
for the slopes (pixel intensity versus time) using the Student’s t test. *p < 0.01.
(E) Representative images of mitochondrial morphology in exon 5b knock-
down cells after shifting to glycolytic (‘‘Glucose’’) or oxidative (‘‘Acetoacetate’’)
media for 24 hr. Mitochondria were visualized via staining for Tom20, a mito-
chondrial OM protein. Scale bar, 5 mm.
(F) Quantitation of mitochondrial morphology in control and exon 5b-depleted
cells in glycolytic and oxidative media. All error bars indicate standard de-
viations.
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with the expectation that the CCCP effect is operating via cleav-
age of Opa1 (Figure S6B). To formally demonstrate the role of
Oma1, we examined fusion in Oma1 null mitochondria. These
mitochondria show normal OXPHOS-stimulated IM fusion (as
Yme1L is unaffected), but do not show CCCP-stimulated cleav-
age of Opa1 (Figure S6C) nor CCCP-stimulated fusion (Fig-
ure 7F). Taken together, these data indicate that Yme1L and
Oma1 have profusion roles and that artificial cleavage of Opa1
can bypass the block to IM fusion caused by inhibition of
OXPHOS.
DISCUSSION
Previous work defined a requirement for ATP in mitochondrial
fusion (Hoppins et al., 2011; Meeusen et al., 2004; Schauss
et al., 2010). In this study, we show that beyond having an energy
requirement, mitochondrial fusion is sensitive to the OXPHOS
activity of mitochondria. By tuning the levels of mitochondrial
IM fusion to OXPHOS activity, cells may ensure that mitochon-
drial morphology and function match energy demands. Because
OM fusion is insensitive to changes inmitochondrial metabolism,
physiological uncoupling of OM and IM fusion can control overall
fusion rates of the mitochondrial matrix. OXPHOS-stimulated IM
fusion is disturbed in patients with mitochondrial encephalomyo-
pathies. It should be noted that our in vitro assay with isolated
mitochondria appears to primarily measure fusion associated
with Yme1L-mediated cleavage of Opa1. In vivo, we expect
Oma1-mediated cleavage to also be important.
Two distinct models have related Opa1 processing to
mitochondrial fusion. First, both long and short isoforms are
required for membrane fusion (DeVay et al., 2009; Herlan et al.,
2003; Song et al., 2007). As a result, some proteolysis of Opa1
at S1 or S2 is required to produce an appropriate ratio of long
and short isoforms. However, our results indicate that simply
having a normal ratio of long and short isoforms is not sufficient
for IM fusion, because mitochondria incubated acutely with
o-phenanthroline show normal ratios of long and short Opa1
isoforms but have complete loss of IM fusion. Second, collapse
of the mitochondrial IM potential by CCCP induces Oma1-
dependent cleavage at S1 sites, complete loss of l-Opa1, and
loss of mitochondrial fusion (Ehses et al., 2009; Head et al.,
2009; Ishihara et al., 2006). Other conditions that cause mito-
chondrial dysfunction also promote excessive Opa1 cleavage,
leading to the idea that Opa1 cleavage is an antifusion mecha-
nism to prevent the merger of compromised mitochondria
(Duvezin-Caubet et al., 2006). However, long-term depolariza-
tion by CCCP is a nonphysiological condition, and it is difficult
to extrapolate the endogenous function of Oma1 cleavage
from such experiments.
In contrast to these models, our data argue that proteolysis of
Opa1 is a profusion event that operates at the time of fusion (Fig-
ure 7G). Although our study is focused on the bioenergetic regu-
lation of IM fusion, it should be emphasized that Opa1 cleavage
appears to be involved regardless of whether fusion is constitu-
tive or regulated. The importance of real-time cleavage of Opa1
during the fusion reaction is strongly supported by our observa-
tion that artificial cleavage of l-Opa1 is sufficient to drive IM
fusion. We imagine that Opa1 cleavage triggers structural rear-Crangements and/or stimulation of GTPase activity to promote
the fusion reaction. This process ultimately results in a mixed
population of long and short isoforms at steady state. Experi-
ments with Mgm1, the yeast ortholog of Opa1, suggest that
the short isoform has enhanced GTPase activity required for
fusion (DeVay et al., 2009; Herlan et al., 2003). In a possible
scenario, the cleavage of tethered l-Opa1 complexes may stim-
ulate GTPase activity (via production of s-Opa1) and associated
conformational changes to drive membrane fusion. Future
experiments with cell-free fusion assays will be necessary to
determine the molecular details of Opa1 activation. Although
we find that Opa1 cleavage stimulates IM fusion, our results do
not rule out the possibility that uncleaved Opa1 can mediate a
basal level of fusion.
With Opa1 proteolytic cleavage associated with the fusion
mechanism, control of the cleavage step provides an opportu-
nity to regulate fusion. The interaction of two IM proteases with
Opa1 probably enables its activity to be differentially regulated.
With Yme1L (an ATP-dependent protease), OXPHOS or ATP
stimulates cleavage of Opa1 at S2, thereby enhancing IM fusion
in response to metabolic signals. Indeed, cleavage activity at S2
is lower in cells with pathogenicmtDNAmutations (Figure S4E). It
is interesting to note that Yme1L has been reported to interact
with subunits of complex V (Stiburek et al., 2012), raising the
possibility that it may directly sense ATP generation by the res-
piratory chain. Opa1 can also be activated by Oma1-mediated
cleavage at S1, although this mechanism is not engaged during
OXPHOS-stimulated fusion in vitro. Pharmacologic treatment by
CCCP is the best-documented activator of Oma1 (Ehses et al.,
2009; Head et al., 2009). Interestingly, mitochondria are known
to undergo transient depolarizations that correlate with fusion
events (Santo-Domingo et al., 2013), and such events may serve
to stimulate Oma1 activity under basal conditions.EXPERIMENTAL PROCEDURES
Reagents
Antibodies to the following proteins were used: Drp1 (BD Biosciences), Drp1
S637-PO4 (Cell Signaling), Actin (Millipore), Fis1 (Alexis Corps), Mff (Sigma-
Aldrich), Mfn1 (Chen et al., 2003), Mfn2 (Sigma), Opa1 (in house monoclonal),
ClpP (Proteintech Group), Oxa1 (Proteintech Group), Tom20 (Santa Cruz
BioTech), Hsp60 (Santa Cruz BioTech), Yme1L (Proteintech Group), and
Myc (Covance). Oligomycin (Sigma-Aldrich), antimycin A (Sigma-Aldrich), at-
penin A5 (Santa Cruz BioTech), CCCP (Sigma-Aldrich), and atractyloside
(Sigma-Aldrich) were used at 1 mM. Concentrations of other compounds: rote-
none (Sigma-Aldrich), 200 nM; KCN (Sigma-Aldrich), 1 mM; o-phenanthroline
(Sigma-Aldrich), 0.5 mM; aspartate, 1 mM; ADP (Sigma-Aldrich), 200 mM;
b-NADH (Sigma-Aldrich), 2 mM. Unless otherwise indicated, substrates (pyru-
vate, malate, succinate, a-ketoglutarate) were used at 5 mM.
Cell Culture
MEFs were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, and
penicillin/streptomycin at 37C and 5% CO2. 143B (human osteosarcoma)
cells were similarly maintained, except with 5% FBS and the addition of
50 mg/ml uridine. Opa1 null and Oma1 null MEFs were described previously
(Quiro´s et al., 2012; Song et al., 2007). Cells with homoplasmic mtDNA muta-
tions are cybrids from the fusion of enucleated patient cells with 143B rho0
cells (lacking mtDNA) (Baracca et al., 2005; Kwong et al., 2007). ND1 cells
have a G/ A mutation at nucleotide 3460 in the ND1 subunit of complex I.
COXI cells have a premature stop codon at nucleotide 6390 in the cytochrome
c oxidase subunit I gene of complex IV. Stable cell lines with labeledell Metabolism 19, 630–641, April 1, 2014 ª2014 Elsevier Inc. 637
Figure 7. Induced Proteolytic Processing of Opa1 Promotes Inner Membrane Fusion
(A) Schematic of the in vitro fusion experiment in (B) and (C). o-phenanthroline is present throughout, and digitonin and TEV protease are added after OM fusion.
(B) Induction of IM fusion by engineered cleavage at S2. OM and IM fusion events in mitochondria containing Opa1 lacking a TEV site (1DS1) or containing a TEV
site at the S2 position (1DS1 + TEV@S2). In the latter, S2 cleavage was controlled by addition of digitonin and TEV.
(C) Induction of IM fusion by engineered cleavage at S1. The experiment is similar to (B), but using an Opa1 isoform containing a TEV site at the S1 position. Same
color scheme as (B).
(legend continued on next page)
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Opa1 Cleavage Stimulates Mitochondrial Fusionmitochondria were generated by retroviral infection. Fluorescent proteins were
targeted to either the OM (via fusion with the C terminus of OMP25) or the ma-
trix (via fusion with the mitochondrial targeting sequence at the N terminus of
COX8). Highly fluorescent clonal populations were selected for use in the
in vitro mitochondrial fusion assay. Mitochondrial morphology was scored in
triplicate with greater than 100 cells per experiment.
To quantify S1 and S2 processing, wild-type MEFs were stably infected with
retroviruses encoding either mouse Opa1 isoform 1 (S1 site only), or mouse
Opa1 isoform7DS1 (S1 site [amino acids 191–201] deleted, S2 site present).
For TEV protease experiments, Opa1 null MEFs were stably infected with
retrovirus encoding mouse Opa1 isoform 1DS1 (S1 site deleted) with a TEV
protease site (GENLYFQ) inserted at either the S1 site (after amino acid 190)
or at the S2 (exon 5b; after amino acid 208) site.
shRNAi against Yme1L was performed as described previously (Song et al.,
2007). The targeted sequence of Yme1LwasGAGTGGCAGAGGAACTCATAT.
Infected MEFs were plated at low density to obtain clonal populations with
stable knockdown of Yme1L. Yme1L-knockdown cells were rescued by infec-
tion with retroviruses encoding RNAi-resistant mouse Yme1L.
siRNA against exon5b of mouse Opa1 was performed using two separate
sequences. siRNA oligonucleotides were purchased from Integrated DNA
Technologies.
Exon 5b siRNA#1:
Sense: 50-rGrCrArCrGrArArGrArGrGrArArGrCrArCrGrCrArGrArGdCdC-30
Antisense: 50-rGrGrCrUrCrUrGrCrGrUrGrCrUrUrCrCrUrCrUrUrCrGrUrGr
CrUrC-30
Exon 5b siRNA#2:
Sense: 50-rCrArUrUrCrUrCrUrUrArCrArArCrArGrCrArArArUrUrCdAdA-30
Antisense: 50- rUrUrGrArArUrUrUrGrCrUrGrUrUrGrUrArArGrArGrArArUr
GrArG-30
Here, ‘‘r’’ refers to a ribonucleic base and ‘‘d’’ refers to a deoxyribonucleic
base. siRNA duplexes were transfected into cells at 50 nM using Lipofect-
amine 2000 (Invitrogen) at the time of cell plating, and again at 24 and 48 hr.
Cells were assayed at 72 hr for their ability to respond to oxidative media.
Customized glycolytic and oxidative media were used. The base DMEM
solution lacks glucose, pyruvate, and glutamine (Invitrogen Catalog
#A14430). Glucose-containing (glycolytic) media were generated by DMEM
supplemented with 10% dialyzed FBS, 10 mM glucose, 4 mM glutamine,
and penicillin/streptomycin. It should be noted that this glycolytic media is
distinct from the standard high-glucose DMEM media used for routine culture
of MEFs. Galactose-containing (oxidative) media were generated by DMEM
supplemented with 10% dialyzed FBS, 10 mM galactose, 4 mM glutamine,
and penicillin/streptomycin. Acetoacetate-containing (oxidative) media were
generated by DMEM supplemented with 10% dialyzed FBS, 10mMacetoace-
tate, 4 mM glutamine, and penicillin/streptomycin. For media exchanges, cells
werewashed three timeswith the indicatedmedia. For starvation experiments,
cells were washed three times and incubated in HBSS (Hank’s Balanced Salt
Solution, Invitrogen Catalog #14025).
Mitochondrial Isolation and In Vitro Mitochondrial Fusion Assay
Mitochondria were isolated from cells via differential centrifugation. Cells were
washed and harvested by scraping in isolation buffer (5 mM HEPES, 200 mM
mannitol, 70 mM sucrose, 70 mM KCl, 0.5 mM EGTA, 5 mM K2HPO4, 1 mM
MgCl2, and HALT protease inhibitors) and lysed via nitrogen cavitation (250
psi, 20 min, 4C). Lysates were cleared of cell debris and nuclei with four(D) Schematic of the in vitro fusion experiment in (E) and (F). Isolatedmitochondria
CCCP is then added to induce Opa1 processing at S1 (Step 2).
(E) Induction of IM fusion by CCCP. OM and IM fusion events in wild-type mi
o-phenanthroline; oligo, oligomycin. Same color scheme as (B).
(F) Same as (E), except using Oma1 null mitochondria. All error bars indicate sta
(G) Model for activation of Opa1 and IM fusion by proteolysis. OM fusion is per
regulated by the Yme1L or Oma1 metalloproteases, which acutely cleave long i
regulated by mitochondrial respiration and/or ATP levels, while Oma1 activity is
C600 g spins. A crude mitochondrial fraction was isolated from the cleared
lysate via a 10,000 g spin and washed three times in isolation buffer.
For the in vitro fusion assay, we utilized a procedure similar to previously
reported assays (Hoppins et al., 2011; Meeusen et al., 2004; Schauss et al.,
2010). Differentially labeled mitochondria were mixed and pelleted at
10,000 g for 2 min to promote interaction. After 20 min on ice, the pellet was
resuspended and incubated at 37C for 60 min in the presence of additional
additives (e.g., substrate, GTP, ATP, ADP, drugs) and then fixed at room
temperature with an equal volume of formalin. Mitochondria were visualized
under a fluorescent microscope and scored according to colocalization
of different fluorescent proteins as described in the text. Approximately
100–200 mitochondria were counted per reaction; reactions were performed
in triplicate.
For the induced cleavage reactions (Figure 7), step 1 (OM fusion only) was
performed at 37C for 30 min in the presence of the indicated additives. After
30 min, additional additives (e.g., digitonin, TEV protease [Invitrogen; 1 unit/
reaction], and CCCP [1 mM]) were added, and the reaction was incubated at
37C for an additional 30 min (step 2), followed by fixation and analysis. For
proteinase K experiments, mitochondria after step 1 were incubated on ice
in the presence of different concentrations of digitonin (0.02%–0.1%). Protein-
ase K was added (final concentration 10 mg/ml), and the reactions were
incubated for 10 min on ice. The reaction was stopped by pelleting the mito-
chondria and resuspending them in lysis buffer (2% SDS, 25 mM Tris
[pH 6.8]) with PMSF supplemented to 1 mM.
In Vivo Mitochondrial Fusion Assay
Cells expressing matrix DsRed and photoactivatable GFP (PA-GFP) targeted
to either the OM or matrix were plated on glass coverslips and imaged live
at 37C on an LSM 710 confocal microscope (Carl Zeiss, Inc.). PA-GFP was
photoactivated in a region of interest (5 mm 3 5 mm) by illumination with a
405 nm laser. The activated fluorescent signal was then collected (for the entire
cell) every 3 min for the next 30 min using a spectral detector, followed by
spectral unmixing based on the individual PA-GFP and DsRed spectra. Fusion
events result in the dilution of the activated signal. The average pixel intensity
(for the entire cell) over time is a measurement of fusion rates (Karbowski et al.,
2004). Images were analyzed in MatLab (Mathworks, Inc.). p values were
calculated using a Student’s t test on the slopes of intensity versus time for in-
dividual measurements (>20 per condition).
To follow individual fusion events, cells expressing matrix DsRed and
OM-PA-GFP were imaged on glass coverslips at 37C. Simultaneous photo-
activation of PA-GFP (with a 405 nm laser) and bleaching of matrix DsRed
(with a 561 nm laser) was used to label specific mitochondria. Images were
collected (as above) every 20 s for 10 min and analyzed manually for fusion
events.
Respiration and Membrane Potential Measurements
Oxygen consumption rate was measured in a Seahorse Biosciences Extracel-
lular Flux Analyzer (model XF96). A total of 10,000 cells per well were plated
18 hr prior to measurement in complete medium in a 96-well plate. Four hours
prior to measurement, cells were equilibrated in media made with DMEM
lacking bicarbonate (Sigma-Aldrich Catalog #D5030). Oxygen levels were
measured over 5 min periods, and media exchange was performed using
the XF96 PrepStation (Seahorse Bioscience).
Respiration measurements on isolated mitochondria were performed as
previously described (Rogers et al., 2011). Briefly, in vitro fusion assays were
set up (as described above) in 100 ml reaction volumes. Fifty microliter (2 mg
mitochondrial protein) aliquots of each reaction were placed in a 96-wellare allowed to proceed throughOM fusion (Step 1) in the absence of respiration.
tochondria after CCCP-induced processing of Opa1. Suc, succinate; o-phe,
ndard deviations.
missive, as long as mitofusins and GTP are present. In contrast, IM fusion is
soforms of Opa1 (L-Opa1) as part of the fusion mechanism. Yme1L activity is
potentially regulated by transient IM depolarizations.
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Opa1 Cleavage Stimulates Mitochondrial FusionSeahorse TC plate. The plate was spun at 2,000 g, 4C for 20 min to pellet
mitochondria. Additional isolation buffer was added to a final volume of
200 ml. The plate was equilibrated for 10min at 37Cprior tomeasuring oxygen
consumption. Oxygen levels were measured over 5 min periods.
Membrane potential measurements on isolated mitochondria were
performed by visualization of TMRM fluorescence. Mitochondria from the
indicated condition were loaded with TMRM (10 nM) for 10 min at room
temperature and then washed into isolation buffer containing 2 nM TMRM.
Samples were imaged by fluorescence microscopy using identical imaging
parameters. The average fluorescence for each mitochondrion (after subtrac-
tion of background fluorescence) was calculated. More than 100mitochondria
were quantified per sample, and experiments were performed in triplicate.
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